FDA Clearance Tracker · P160052
PartoSure test
Last checked: Nov 20, 2026Latest source record: Apr 11, 2018 (this decision)Source: openFDAMethods & limitations
Decided
Apr 11, 2018
Approved
Time to decision
497 days
Received Nov 30, 2016. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P160052
- Device name
- PartoSure test
- Applicant
- Qiagen, Inc.
- Applicant location
- Germantown, MD
- Received
- Nov 30, 2016
- Decided
- Apr 11, 2018
- Decision
- Approved
- Supplements
- 1 in FDA's data for this PMA. See them on the FDA record
Device type
- Device class
- Class III
- Specialty
- Laboratory Medicine & Pathology
FDA's approval statement
As written in FDA's record.
Approval for the PartoSure test. The device is a rapid, qualitative test for detecting the presence of placental alpha microglobulin 1 (PAMG-1) in cervicovaginal secretions. The device is indicated as an aid to rapidly assess the risk of spontaneous preterm delivery in <= 7 days from the time of cervicovaginal sample collection in pregnant women with signs and symptoms of early preterm labor, intact amniotic membranes and minimal cervical dilatation (<3 cm), sampled between 24 weeks, 0 days and 34 weeks, 6 days gestation in women with a singleton gestation.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- This is the earliest decision in FDA's data under product code QBB (Placental alpha microglobulin-1 immunoassay).
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Qiagen, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- ipsogen JAK2 RGQ PCR Kit510(k)
K172287 · Decided Jan 12, 2018 · 168 days after receipt
Device type: Jak2 Gene Mutation Detection Test (PSU) · Laboratory Medicine & Pathology
- ipsogen JAK2 RGQ PCR KitNew device typeDe Novo
DEN160028 · Decided Mar 27, 2017 · 269 days after receipt
Device type: Jak2 Gene Mutation Detection Test (PSU) · Laboratory Medicine & Pathology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.